MRKMerck & Co., Inc.

MRK Stock Price, Valuation & Chart | Merck & Co., Inc.

Compare

$145.60+3.22 (+2.26%)

At close · 09 Oct 2026, 08:02 pm

Sector: Healthcare Industry: Drug Manufacturers - General

Overview Financials Dividends Ratios

MRK Historical price chart

MRK Key Stats

Market Capitalization359.61B

PE Ratio45.36

EPS3.21

Trading Volume8.00M

Today's High/Low146.68/141.36

Dividend Yield2.34

52 Week High/Low156.92/82.01

Shares Outstanding2.47B

MRK Financial Statement

MRK Analyst ratings

MRK Analysis & performance metrics

MRK Company profile

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human…

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and…

MRK Management team

Name

Position

David Michael WilliamsCTO

Executive Vice President and Chief Information & Digital Officer

Jennifer L. Zachary J.D.

Executive Vice President & General Counsel

Dean Y. Li M.D., Ph.D.

Executive Vice President & President of Merck Research Laboratories

Betty D. Larson

Executive Vice President & Chief Human Resources Officer

Cristal N. Downing

Executive Vice President and Chief Communications & Public Affairs Officer

Robert M. Davis J.D.CEO

Chairman, President & Chief Executive Officer

Caroline A. LitchfieldCFO

Executive Vice President & Chief Financial Officer

Richard R. DeLuca Jr.

Executive Vice President & President of Merck Animal Health

Name

Position

David Michael WilliamsCTO

Executive Vice President and Chief Information & Digital Officer

Jennifer L. Zachary J.D.

Executive Vice President & General Counsel

Dean Y. Li M.D., Ph.D.

Executive Vice President & President of Merck Research Laboratories

Betty D. Larson

Executive Vice President & Chief Human Resources Officer

Cristal N. Downing

Executive Vice President and Chief Communications & Public Affairs Officer

Robert M. Davis J.D.CEO

Chairman, President & Chief Executive Officer

Caroline A. LitchfieldCFO

Executive Vice President & Chief Financial Officer

Richard R. DeLuca Jr.

Executive Vice President & President of Merck Animal Health

Management Team

David Michael WilliamsCTO

Executive Vice President and Chief Information & Digital Officer

Jennifer L. Zachary J.D.

Executive Vice President & General Counsel

Dean Y. Li M.D., Ph.D.

Executive Vice President & President of Merck Research Laboratories

Betty D. Larson

Executive Vice President & Chief Human Resources Officer

Cristal N. Downing

Executive Vice President and Chief Communications & Public Affairs Officer

Robert M. Davis J.D.CEO

Chairman, President & Chief Executive Officer

Caroline A. LitchfieldCFO

Executive Vice President & Chief Financial Officer

Richard R. DeLuca Jr.

Executive Vice President & President of Merck Animal Health

Management

David Michael WilliamsCTO

Executive Vice President and Chief Information & Digital Officer

Jennifer L. Zachary J.D.

Executive Vice President & General Counsel

Dean Y. Li M.D., Ph.D.

Executive Vice President & President of Merck Research Laboratories

Betty D. Larson

Executive Vice President & Chief Human Resources Officer

Cristal N. Downing

Executive Vice President and Chief Communications & Public Affairs Officer

Robert M. Davis J.D.CEO

Chairman, President & Chief Executive Officer

Caroline A. LitchfieldCFO

Executive Vice President & Chief Financial Officer

Richard R. DeLuca Jr.

Executive Vice President & President of Merck Animal Health

Total 8 executives

MRK Frequently asked questions

What is Merck & Co., Inc. (MRK) Stock Price?

Current stock price of Merck & Co., Inc. (MRK) stock is $145.60. The stock price is +2.26% higher in the session. The intraday range can be seen from this page. Volume of Merck & Co., Inc. (MRK) stock is 8.00M.

Last updated at 09 Oct 2026, 08:02 pm.

Why is the Merck & Co., Inc. (MRK) stock price going up or down today?

The stock price of Merck & Co., Inc. (MRK) can change with earnings, company news, and overall market sentiment. Merck & Co., Inc. operates in the Healthcare / Drug Manufacturers - General market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Merck & Co., Inc. stock expensive at its current price?

Whether Merck & Co., Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for MRK on this page is 45.36. EPS on this page is 3.21. Compare those figures with peers and growth expectations before deciding if the current Merck & Co., Inc. price is justified.

How has the stock price of Merck & Co., Inc. (MRK) performed historically?

Historical performance for Merck & Co., Inc. (MRK) is shown on the price chart on this page. Review multi-period moves alongside volume to see how MRK reacted to past earnings and market events.

Should I buy Merck & Co., Inc. (MRK) stock, at this price?

Buying Merck & Co., Inc. (MRK) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.